NEWSROOM
Press Releases by Agendia
News
Press Releases
Agendia Presents New Data Demonstrating MammaPrint’s Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients at the European Society for Medical Oncology Virtual Congress
Irvine, California – September 17, 2020 – Agendia, Inc., a world leader in precision oncology for breast cancer, today presented data at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 showing that MammaPrint’s Read More
Agendia to Showcase New Data at the European Society for Medical Oncology Virtual Congress 2020
IRVINE, Calif., Sept. 14, 2020 /CNW/ - Agendia, Inc. a world leader in precision oncology for breast cancer today announced that new clinical data from its ongoing research in breast cancer is to be presented at the upcoming European Read More
MINDACT Study Shows MammaPrint® Provides Widespread Health System Cost Savings
Analysis Published in European Journal of Cancer Use of MammaPrint genomic assay alongside clinical assessment is cost-effective versus clinical assessment alone IRVINE, Calif., Aug. 25, 2020 - Agendia, Inc., a world leader in precision oncology for breast Read More
Agendia Included on the 2020 Inc. 5000 List With Three-Year Revenue Growth Approaching 90%
Inc. Magazine Unveils Its Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000 NEW YORK, August 14, 2020 – This week, Inc. magazine revealed that Agendia, Inc. has been included on its annual Inc. 5000 Read More
Agendia Expands Management Team to Meet Company Momentum, Appoints Brian Dow as Chief Financial Officer
Chief Operating Officer Kurt Becker to Take on Broadened Role Overseeing Global Operations and Research and Development Irvine, California., July 29, 2020 – Agendia, Inc., a world leader in precision oncology for breast cancer, today announced Read More
Agendia Publishes Unprecedented Full Genome Dataset from MINDACT Trial for the Advancement of Translational Research in Communications Biology
PRESS RELEASE Irvine, California., July 27, 2020 – Agendia, Inc., a world leader in precision oncology for breast cancer, today announced the publication of MINDACT trial data in the July 27 issue of Communications Biology, a Read More
General Standby Statement
Agendia, Inc. has entered into a Settlement Agreement with the U.S. Department of Justice (DOJ) acting on behalf of the Office of Inspector General of the Department of Health and Human Services (OIG-HHS) to resolve Read More
